Company intelligence / Profile preview

Homeostasis Therapeutics

Bronx, New York, United Stateshomeostasistherapeuticsllc.com ↗

Ownership: Private
Development stage: Phase 2

Overview

Initial case studies and a small clinical trial suggest the combination of ketogenic diet followed by ketamine infusions may induce remission in severe, chronic anorexia nervosa. Several patients have experienced significant improvement and sustained remission. A larger, randomized controlled trial with UC San Diego is being initiated to further evaluate efficacy and safety.

Therapeutic areas: Psychiatry
Modalities: Ketogenic diet (metabolic intervention)Ketamine infusions (psychedelic/psychiatric intervention)
Industry: Biotech

Drug pipeline

1 asset

ketamine

Phase 2

Indications: Anorexia nervosa, Bulimia nervosa

Partnerships

University of California, San Diego – collaboration on upcoming randomized clinical trial

Beyond the preview

Go deeper on Homeostasis Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Homeostasis Therapeutics.

Explore the full profile